-
STRATEGIC MARKET ACCESS PLANNING IN BREAST AND LUNG CANCER ENABLED BYREAL-TIMEAI-ASSISTEDLIVINGSYSTEMATICLITERATUREREVIEW (REAL-SLR)SYSTEM
Mar 18, 2026, 21:38 PM -
POST-STROKE HEALTH-RELATED QUALITY OF LIFE AND RETURN TO WORK IN SOUTHWESTERN ETHIOPIA: A MIXED-METHODS STUDY
Mar 18, 2026, 21:38 PM -
STUDY ON PHARMACISTS' AWARENESS ON VACCINATION IN PHARMACIES DURING WARTIME IN UKRAINE
Mar 18, 2026, 21:38 PM -
FINANCIAL TOXICITY OF LECANEMAB IN CHINA: COMPARATIVE ANALYSIS OF VIAL SHARING, REGIONAL INSURANCE, AND TREATMENT PERSISTENCE
Mar 18, 2026, 21:38 PM -
POST-2020 REAL-WORLD EVIDENCE ON PHARMACOTHERAPIES FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS OF COMMUNITY-BASED AND HOME-BASED HEALTH INTERVENTIONS FOR HEALTHY AGING IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
Mar 18, 2026, 21:38 PM -
STANDARDIZING AN ANNUAL REFERENCE COMPARATOR OF HEALTHCARE UTILIZATION OF PAINFUL DIABETIC NEUROPATHY (PDPN): A U.S. CLAIMS COHORT META-ANALYSIS FOR MODELING AND PAYER BENCHMARKING
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
PROJECTED IMPACT OF PERSONALIZED MRNA NEOANTIGEN CANCER VACCINES IN MEDICARE: A SCENARIO ANALYSIS USING TRIAL EFFICACY AND LINKED DATA POPULATION ESTIMATES
Mar 18, 2026, 21:38 PM -
CAREGIVER-DEFINED UNMET NEEDS TO SUPPORT PATIENT-CENTERED TRIAL DESIGN AND VALUE CONSIDERATIONS IN MULTIPLE SULFATASE DEFICIENCY (MSD)
Mar 18, 2026, 21:38 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT ASSESSMENT OF HORMONAL IUD USE IN REDUCING UNPLANNED PREGNANCIES IN BRAZIL: REAL-WORLD ANALYSIS FROM A BRAZILIAN HEALTH INSURANCE COMPANY
Mar 18, 2026, 21:38 PM -
REAL-WORLD COST-EFFECTIVENESS AND OPPORTUNITY COSTS OF ANTI-IL-17/23 VERSUS ANTI-TNF? THERAPIES FOR PSORIASIS USING DLQI
Mar 18, 2026, 21:38 PM -
PRICE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION
Mar 18, 2026, 21:38 PM -
NATIONAL TRENDS IN CATASTROPHIC HEALTH EXPENDITURE AND OUT-OF-POCKET SPENDING AMONG U.S. OLDER ADULTS WITH DEMENTIA: 2012-2021
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
PREVALENCE AND HEALTHCARE BURDEN OF COMPLICATED URINARY TRACT INFECTIONS AMONG HOSPITALIZED PATIENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND EVALUATION OF ERADICATION EFFICIENCY OF NOVEL GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR THE TREATMENT OF H. PYLORIINFECTION
Mar 18, 2026, 21:38 PM
